Best CBD Penny Stocks to Watch Closely Right Now

CBD penny stocks

The stock markets are now at historic lows, which actually may present a once-in-a-decade opportunity to buy quality stocks at cheap prices. There are plenty of stocks that have declined massively, yet many of those stocks have the potential of delivering strong returns in the long-term. For instance, investors could consider having a look at some of the CBD penny stocks in the market if they are looking to invest in a sector with the potential to grow in the long-term. The pot industry may have had a tough time over the past months, but in the long-term, analysts expect the industry to grow.

The sell-off in the wider market affected CBD penny stocks considerably in recent days, and many of those stocks have dropped to historic lows in recent times. However, this is the sort of situation where investors may consider picking up promising stocks at significant bargains. The CBD sector is highly promising and, if experts are to be believed, it could grow into a multibillion-dollar industry in the years to come.

Here is a closer look at 3 highly promising CBD penny stocks:

Best CBD Penny Stocks to Watch Closely: Aphria Inc (TSX:APHA) (NYSE:APHA)

CBD penny stocks

One CBD penny stock that ought to be on the radars of many investors at this point in time is Aphria. One of the most compelling arguments in favor of Aphria is the fact that it is one of the few companies in the cannabis sector that has recorded profits. In two out of the previous three quarters, Aphria recorded profits. However, there is one thing that needs to be kept in mind about APHA stock.

Unlike many other CBD penny stocks in the market, Aphria stock has not declined by as much. Sure, over the past year, it has crashed by 70%, but that is nothing compared to other companies like Aurora Cannabis (TSX:ACB) (NYSE:ACB) or Tilray (NASDAQ:TLRY). APHA stock is trading at $3.50 a share right now, which could be a bargain, considering the fact that it has price to sales ratio of below 3 at this point.

>> Are These 3 Cannabis Stocks Set to Recover in April?

Market watchers believe that Aphria stock could well be one of the major bargains in the market right now. Investors could do well to put Aphria stock on their watch lists.

Best CBD Penny Stocks to Watch Closely: Curaleaf Holdings (CSE:CURA) (OTCQX:CURLF)

Another interesting CBD stock that could be tracked by investors is Curaleaf Holdings. Curaleaf released its financial results for the fourth quarter on March 24, which showed that it beat analysts’ revenue estimates. The company recorded total sales of $75.5 million, which proved to be a massive improvement on year-on-year. In the year-ago period, it generated $32 million in sales. In the fourth quarter, Curaleaf posted a loss of $26.6 million.

Analysts had projected revenues of $74.7 million for the quarter. The performance could prove to be a positive trigger for the stock in the coming days, so investors may want to keep an eye on it. In 2019, Curaleaf generated revenues of $221 million, and currently, it has a market cap of $1.9 billion. The stock is currently trading at 5 times its actual book value, and while that is expensive, it should be noted that it has recorded higher sales than peers like Aurora Cannabis or Aphria.

Curaleaf can also tap into the growing United States market in a big way, so one can argue that investors might be willing to pay a premium for Curaleaf stock.

Best CBD Penny Stocks to Watch Closely: Organigram Holdings (TSX:OGI) (NASDAQ:OGI)

CBD penny stocks

One company that seems well-placed to tackle the current situation is Organigram Holdings. Organigram may not be one of the most cash-rich cannabis operators in the industry, but it does run a highly efficient operation, which could well be one of its major competitive advantages.

In addition to that, investors should also note that it is one of the few cannabis firms in Canada that has signed supply agreements with all 10 provinces in the country. Organigram is also the only big-ticket grower that is present in the Eastern Atlantic region, which gives the company the opportunity to corner a major market. It should be noted that this region has higher usage rates for cannabis than the Canadian average.

The company only owns one major facility, but this allows it to effectively control its production capabilities as per market demand. So, Organigram could be an interesting CBD penny stock to watch this month.

>> Read More Penny Stock News

Featured image: DepositPhotos © EdZbarzhyvetsky

Please See Disclaimer

Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of or its officers. The author is wholly responsible for the validity of all statements. was not involved in any aspect of the article preparation. The author was not paid by Market Jar Media Inc for this article. The author did not pay to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. does not render general or specific investment advice. Any information on should not be considered a recommendation to buy or sell any security. does not endorse or recommend the business, products, services or securities of any company mentioned on

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.